## SECTION III - METHODOLOGICAL RIGOR (NICE DSU TSD 7)

### 30. Definition of Decision Problem

| Item | Assessment Criterion                                                                                                                                     | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | -------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 30.1 | **Population Heterogeneity**: Are potential modifiers of treatment effect considered a priori (based on clinical opinion/literature)?                    | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 30.2 | **Population Alignment**: If trials include patients outside target population, are assumptions about impact on relative effects justified?              | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 30.3 | **Within-Population Heterogeneity**: Are differences in trial populations within target addressed (age, severity, prior treatment)?                      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 30.4 | **Trial Inclusion Completeness**: Have ALL trials involving ≥2 comparators been included (or exclusions justified)?                                      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 30.5 | **Outcome Completeness**: Have ALL relevant outcome formats been included or synthesized coherently (hazard ratios, median times, multiple time points)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 30.6 | **Additional Modeling**: If dose-response or component-analysis models used, is their validity supported by literature/plausibility?                     | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 31. Methods of Analysis

| Item | Assessment Criterion                                                                                                                                                                        | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 31.1 | **Statistical Soundness**: Is the meta-analytic method statistically appropriate for the data (e.g., no 0.5 zero-cell corrections for strong effects, appropriate handling of rare events)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 31.2 | **Heterogeneity Quantification**: Are numerical estimates of heterogeneity provided (τ², I², between-study SD)?                                                                             | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 31.3 | **Model Selection Justification**: Is choice between fixed/random effects justified (DIC, clinical reasoning, heterogeneity magnitude)?                                                     | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 31.4 | **Heterogeneity Response**: If substantial heterogeneity exists, has appropriate response been undertaken (covariate adjustment, bias adjustment, investigation)?                           | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 31.5 | **Robustness to Heterogeneity**: Does unexplained heterogeneity threaten conclusion validity? Should predictive distributions be used?                                                      | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 31.6 | **Baseline Heterogeneity**: Has heterogeneity in control/placebo arms been discussed as indicator of population heterogeneity?                                                              | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 31.7 | **Baseline Independence**: Are baseline and relative effects modeled independently (to avoid biasing treatment effects)?                                                                    | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 31.8 | **Baseline Data Source**: Is the source of baseline model data justified (placebo arms, external data, subset selection)?                                                                   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 32. Network-Specific Issues

| Item | Assessment Criterion                                                                                                                                       | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | ---------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 32.1 | **Multi-Arm Correlation**: In multi-arm trials, are correlations between treatment effects appropriately accounted for?                                    | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 32.2 | **Network Connectivity**: Is the network connected? If disconnected, are methods to connect the network justified?                                         | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 32.3 | **Inconsistency Potential**: Are there a priori clinical reasons to suspect inconsistency (systematic differences in populations across comparison types)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 32.4 | **Inconsistency Detection**: Have adequate inconsistency checks been performed (loop-specific, node-split, design-by-treatment, outlier detection)?        | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 32.5 | **Inconsistency Resolution**: If inconsistency detected, are adjustments justified (trial exclusion, bias parameters, investigation of causes)?            | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

### 33. Economic Model Integration

| Item | Assessment Criterion                                                                                                                               | Rating                                                                                                                                                  | Evidence/Comments |
| ---- | -------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------- |
| 33.1 | **Uncertainty Propagation**: Has parameter uncertainty been propagated through cost-effectiveness models probabilistically?                        | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 33.2 | **Correlation Preservation**: Have correlations between parameters been preserved in economic models (between treatments, from common baseline)?   | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |
| 33.3 | **Natural History Model**: Can longer-term treatment differences be explained by trial outcomes (treatment-independence of downstream parameters)? | <input type="checkbox" unchecked id="ca5248"> ✓ <br><input type="checkbox" unchecked id="57bf61"> ⚠ <br><input type="checkbox" unchecked id="adb4a4"> ✗ |                   |

---
